It has been shown in mouse models that homozygous deletion of this gene leads to pancreatic agenesis [77], while heterozygous mutations, such as in patients with PDX1/IPF1 MODY, lead to impaired insulin production and hyperglycemia [78]. The gene discussed is INS; the disease is Hyperglycemia.